Pillar Pharmaceuticals 6 L.P. 13D and 13G filings for Idera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-05 4:35 pm Unchanged | 2022-09-27 | 13D | IDERA PHARMACEUTICALS, INC IDRA | Pillar Pharmaceuticals 6 L.P. | 1,007,918 19.900% | 0 (Unchanged) | Filing |
| 2022-06-30 5:58 pm Unchanged | 2022-06-30 | 13D | IDERA PHARMACEUTICALS, INC IDRA | Pillar Pharmaceuticals 6 L.P. | 1,007,918 19.900% | 0 (Unchanged) | Filing |
| 2022-06-24 4:54 pm Unchanged | 2022-06-09 | 13D | IDERA PHARMACEUTICALS, INC IDRA | Pillar Pharmaceuticals 6 L.P. | 1,007,918 19.900% | 0 (Unchanged) | Filing |